Avenu Medical

Dana Point, United States Founded: 2010 • Age: 16 yrs Acquired By Medtronic
Image-guided catheter system is used for percutaneous AV fistula creation.

About Avenu Medical

Avenu Medical is a Healthcare company based in Dana Point (United States) founded in 2010, and was acquired by Medtronic in September 2020. Image-guided catheter system is used for percutaneous AV fistula creation. Avenu Medical has raised $35.96 million across 5 funding rounds from investors including Medtronic. Avenu Medical offers products and services including Ellipsys Vascular Access System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Avenu Medical, Inc. Its competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation; 3 of its 3 listed competitors have raised funding.

Company details

Avenu Medical was founded in 2010 in Dana Point, United States, focusing on the hemodialysis and vascular access sector. The Ellipsys Vascular Access System, an image-guided catheter, is employed to percutaneously form arteriovenous fistulas for hemodialysis patients. FDA approval has been granted for initiating a pivotal Phase III clinical trial under an IDE Exemption, supporting clinical evaluation in the US market.

  • Headquarters Dana Point, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website avenumedical.com
  • Acquired by Medtronic (Sep 2020)
  • Legal Name Avenu Medical, Inc.
Key Metrics
  • Total Equity Funding
    $35.96M (USD)

    in 5 rounds

  • Latest Funding Round
    $12M (USD), Series C

    Oct 2018

  • Investors
  • Acquired by
    Medtronic

    (Sep 2020)

Products & Services of Avenu Medical

Avenu Medical offers a comprehensive portfolio of products and services, including Ellipsys Vascular Access System.

Ellipsys Vascular Access System
Medical Device

Enables minimally invasive AV fistula creation for hemodialysis patients.

Funding Insights of Avenu Medical

Avenu Medical has successfully raised a total of $35.96M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $12 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $35.96M
  • Total Rounds 5
  • Last Round Series C β€” $12M
  • First Round $1M

    (Sep 2010)

All 5 funding rounds of Avenu Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2018$12MSeries C––
–
Feb 2017$13.11MSeries C––
–
Dec 2015$6MSeries B––
–
Jul 2013$3.86MSeries A––
–
Sep 2010$1MSeed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Avenu Medical

Avenu Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medtronic.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Medical equipment for treating over 30 chronic diseases is developed.
1949medtronic.comMinneapolis, United States
Premium access

Investor details for Avenu Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Avenu Medical

16 people are tracked at Avenu Medical (8 in leadership, 3 in board & advisors, 5 in team).

NameRoleGroup
Mark A. Ritchart
President & CEOLeadership
J. David Campbell
VP, Quality Assurance & Regulatory AffairsLeadership
Ed L. Chang
Chief Marketing OfficerLeadership
Frank A. Hettmann
CFOLeadership
Gene B. Reu
EVP & General ManagerLeadership
Dan Beney
VP, SalesLeadership
Brian Driscoll
VP, MarketingLeadership
Brad Kellerman
VP, Research & DevelopmentLeadership
T. Spencer Williamson
DirectorBoard & advisors
Thomas W. McCandlish
DirectorBoard & advisors
Steve H. Parker
Co-founder, Chairman & DirectorBoard & advisors
Horacio Almazan
Operations ManagerTeam
Dk Kim
Sr. Quality EngineerTeam
Julie Herweg Rvt
Clinical Application SpecialistTeam
Crystal Zerbe Lee
Clinical Application SpecialistTeam
Andrea Wampler
Clinical Application SpecialistTeam
Premium access

Complete people profiles for Avenu Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Avenu Medical

4 dated milestones of Avenu Medical across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Avenu Medical is founded.
  2. Funding First funding round of $1.0M.
  3. Funding Latest funding round, Series C, of $12.0M.
  4. Exit Acquired by Medtronic.

Competitors of Avenu Medical

Avenu Medical has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Aziyo Biologics and EKOS Corporation.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cardivamedical.com2002Santa Clara, United States$169.45M158
A device for vascular access management is developed.
aziyo.com2015Silver Spring, United States$49.59M162
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
ekoscorp.com1995Bothell, United States$58.8M
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
Premium access

Detailed competitors of Avenu Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Avenu Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Avenu Medical

Premium access

Complete news archive for Avenu Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avenu Medical

Avenu Medical was founded in 2010.

Avenu Medical is headquartered in Dana Point, United States. It is registered at Dana Point, California, United States.

Avenu Medical is a funded company, having raised a total of $35.96M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Sep 2010.

Avenu Medical was founded in 2010 in Dana Point, United States, focusing on the hemodialysis and vascular access sector. The Ellipsys Vascular Access System, an image-guided catheter, is employed to percutaneously form arteriovenous fistulas for hemodialysis patients. FDA approval has been granted for initiating a pivotal Phase III clinical trial under an IDE Exemption, supporting clinical evaluation in the US market.

Avenu Medical's top competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation.

Avenu Medical offers Ellipsys Vascular Access System.

Avenu Medical has 1 investor. Key investors include Medtronic.

Avenu Medical operates through Avenu Medical, Inc..

Yes. Avenu Medical was acquired by Medtronic in September 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available